AdaptHealth Corp. Common Stock AHCO
$5.81
+1.93%
at last close
Analyst Consensus
- Consensus Rating
- Buy (7 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $11.86
- Implied Upside
- +104.1%
- Price Target Range
- $8.00 – $16.00
- Analysts (12 mo)
- 7
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-06 | UBSKevin Caliendo |
Maintains | Buy | $14 → $10 |
| 2026-08-06 | RBC CapitalBen Hendrix |
Maintains | Outperform | $15 → $8 |
| 2026-08-05 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $14 → $9 |
| 2026-07-21 | JefferiesBrian Tanquilut |
Upgrades | Hold → Buy | $11 → $13 |
| 2026-07-06 | BairdEric Coldwell |
Maintains | Outperform | $18 → $15 |
| 2026-05-11 | RBC CapitalBen Hendrix |
Maintains | Outperform | $13 → $15 |
| 2026-05-06 | Canaccord GenuityRichard Close |
Maintains | Buy | $14 → $16 |
| 2026-05-06 | UBSKevin Caliendo |
Maintains | Buy | $15 → $14 |
| 2026-04-13 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $13 → $14 |
| 2026-02-26 | Leerink PartnersWhit Mayo |
Maintains | Outperform | $13 → $12 |
| 2025-11-06 | Canaccord GenuityRichard Close |
Maintains | Buy | $14 → $15 |
| 2025-05-12 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $14 → $13 |
| 2025-05-08 | RBC CapitalBen Hendrix |
Maintains | Outperform | $14 → $13 |
| 2025-02-27 | BairdEric Coldwell |
Maintains | Outperform | $14 → $16 |
| 2025-02-26 | Canaccord GenuityRichard Close |
Maintains | Buy | $13 → $14 |
| 2025-02-26 | RBC CapitalBen Hendrix |
Maintains | Outperform | $11 → $14 |
| 2025-02-26 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $12 → $14 |
| 2025-02-13 | UBSWhit Mayo |
Maintains | Buy | $12 → $11 |
| 2024-11-19 | RBC CapitalBen Hendrix |
Maintains | Outperform | $13 → $11 |
| 2024-11-15 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $13 → $12 |
| 2024-11-06 | UBSWhit Mayo |
Maintains | Buy | $13 → $12 |
| 2024-11-06 | Canaccord GenuityRichard Close |
Maintains | Buy | $14 → $13 |
| 2024-11-06 | BairdEric Coldwell |
Maintains | Outperform | $16 → $14 |
| 2024-08-12 | RBC CapitalBen Hendrix |
Reiterates | Outperform | $13 |
| 2024-05-15 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $13 |
| 2024-03-04 | RBC CapitalBen Hendrix |
Reiterates | Outperform | $13 |
| 2024-02-28 | UBSWhit Mayo |
Maintains | Buy | $9 → $13 |
| 2024-02-28 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $11 → $13 |
| 2024-01-29 | UBSWhit Mayo |
Maintains | Buy | $10 → $9 |
| 2023-11-08 | RBC CapitalBen Hendrix |
Maintains | Outperform | $18 → $13 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $5.81
- Market Cap
- $769.77 million
- 52-Week Range
- $5.21 – $13.43
- Average Volume
- 2.99 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.